Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies

NCT00013533 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Hodgkin Lymphoma
Lymphocytic Leukemia
Mixed Cell Leukemia
Myelodysplastic Syndrome
Non Hodgkin's Lymphoma
CML
ALL
AML
Lymphoma

Interventions

PROCEDURE: Stem cell transplantation

Sponsor

National Cancer Institute (NCI)